The trademark application TRACER was filed by Voyager Therapeutics, Inc., a U.S. corporation (the "Applicant"). Application refused.
The application was filed in English (German was selected as the second language).
The Appeal with reference B R2180/2022-4 was Application rejected according to Article 7(1)(c) EUTMR with decision issued on June 19, 2023 by the EUIPO. The Refusal with reference B 018650628 was Rejected according to Article 7(1)(b) EUTMR with decision issued on September 12, 2022 by the EUIPO.
Goods And Services
The mark was filed in class 42 with following description of goods:
Research and development of platform technologies for genetic delivery of therapies and pharmaceuticals via adeno-associated virus (AAV) capsids
Research, development, and collaboration services in the field of platforms technologies for genetic delivery of therapies and pharmaceuticals via adeno-associated virus (AAV) capsid
Research and development regarding the use of RNA-driven functional screening platforms to discover, research and develop novel capsids for genetic deliver of therapies and pharmaceuticals.